Journal
INFLAMMATION
Volume 29, Issue 2-3, Pages 94-102Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10753-006-9005-z
Keywords
macrophage; CMV promoter; LPS; hypoxia; HIF-1; NF-kappa B
Categories
Funding
- NIGMS NIH HHS [GM 068636-01] Funding Source: Medline
Ask authors/readers for more resources
The cytomegalovirus (CMV) major immediate-early promoter is a strong promoter used for both in vitro and in vivo expression of proteins in signal transduction and gene therapy studies. CMV activity is induced by external stimuli such as endotoxin from Gram-negative bacteria (LPS), TNF-alpha and phorbol esters. This inducibility poses problems when this promoter is used to drive the expression of either wild type or dominant negative mutated proteins as tools in signal transduction studies. This report draws attention to the problem associated with this widely used approach. The role of NF-kappa B and Hypoxia Inducible Factor-1 alpha (HIF-1 alpha) in the transcriptional regulation of Vascular Endothelial Growth Factor (VEGF) in macrophages was investigated using CMV-promoter-driven expression of either wild type or dominant negative proteins involved in these pathways. Difficulties encountered while interpreting the data due to the inducibility of the CMV promoter by LPS are highlighted in this report and provide a cautionary note for the evaluation of data acquired using this approach.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available